Predicting Parkinson's disease trajectory using clinical and neuroimaging baseline measures
Year: 2021
Type: article
Study design: Observational Study
Source: Parkinsonism & Related Disorders
Language: English
Subfield: Cognitive Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Funders: Michael J. Fox Foundation for Parkinson's Research, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, GlaxoSmithKline, Sanofi, Biogen, Teva Pharmaceutical Industries, Celgene, Lyda Hill Foundation, Verily Life Sciences, Voyager Therapeutics, Servier, H. Lundbeck A/S, National Institutes of Health, Genentech, Allergan, Sanofi Genzyme, Avid Radiopharmaceuticals, National Institute on Aging, National Cancer Institute, National Institute of Neurological Disorders and Stroke
OpenAlex ID: W3134403211
